DiagnoCure - Empowering Oncology Decisions
  • Français
  • Site Map
  • Glossary
  • Contact Us
  • Home
  • Career
    • A Career of Passion
    • Talent Wanted
  • Customer
    Service
  • Products and Projects
    • Overview
    • Highlights on Cancer
    • Molecular Diagnostics
    • Bladder Cancer
    • Prostate Cancer
    • Colorectal Cancer
    • Breast Cancer
    • Other R&D Projects
    • Therapeutic Applications
  • News and
    Events
    • Overview
    • Press Releases - DiagnoCure
    • Press Releases - DiagnoCure Oncology Laboratories
    • Events
    • Awards
    • News Alerts
    • Media Room
  • Investors
    • Message to Shareholders
    • Financial Information
    • Management
    • Press Releases
    • Presentations and Conferences
    • Analysts
    • Corporate Governance
    • Investors Contact
  • About
    DiagnoCure
    • Mission and History
    • Board of Directors
    • Management
    • Advisory Board
    • Intellectual Property
  • News and Events
    • Overview
    • Press Releases - DiagnoCure
    • Press Releases - DiagnoCure Oncology Laboratories
    • Events
    • Awards
    • News Alerts
    • Media Room

Press Releases - DiagnoCure Oncology Laboratories

 

   2008-05-29

DiagnoCure Oncology Laboratories introduces Previstage GCC, the first molecular colorectal cancer staging test

 
 

2050 René-Lévesque Blvd W., 6th floor, Québec QC G1V 2K8 CAN

T: (418) 527-6100   F: (418) 527-0240   Toll-free: 1-888-900-6626 (Canada and USA)   communications@diagnocure.com

Terms of Use